Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DJA Global Pharmaceuticals Inc. logo — company profile

DJA Global Pharmaceuticals Inc.

Founded 2001 United States United States 11 employees Biotechnology, Pharmaceutical

General Information

Company Name DJA Global Pharmaceuticals Inc.
Founded Year 2001
Location United States United States +1
Employees 11
Industries Biotechnology, Pharmaceutical
Social

Get notified when DJA Global Pharmaceuticals Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DJA Global Pharmaceuticals Inc.

The goal of DJA is to bridge the complex areas of discovery, pharmaceutical development and global regulatory science. DJA offers: 1. 100+ years collective experience in driving global regulatory approvals for drugs, biologics, combination products and devices. 2. Strategic and operational direction for product lifecycle management in all therapeutic areas. 3. Strategic due-diligence to achieve business objectives. 4. Results-oriented integrated product development involving CROs, CMOs and other external partners. 5. Resolving complex supply chain challenges and averting product recalls. 6. Developing and implementing GxP systems and managing successful agency inspections. 7. eCTD submission & publishing support services Since 2002, DJA has built long-term relationships with 25+ clients who have benefited from: - 8+ NDA/MAA/NDS approvals [including reversal of a non-approval action] in 5 therapeutic areas - 355+ agency submissions [IND/CTA/IDE] in over 30 countries - 40+ DMF/CEP submissions [human/veterinary products] in 28+ countries - 35 successful pre-approval inspections - led 45+ successful FDA/Canadian/EMEA meetings for 30+ products in all phases of development and 8 therapeutic areas

No funding data available for DJA Global Pharmaceuticals Inc. yet.

Get notified when DJA Global Pharmaceuticals Inc. raises funding

DJA Global Pharmaceuticals Inc. Alternatives & Competitors

DJA Global Pharmaceuticals Inc. vs
Syner-G BioPharma Group
Syner-G BioPharma Group United States

To enable our clients to achieve success and enhance human health while inspiring our colleagues to...

Private Equity
242 employees
Health Care, Manufacturing
DJA Global Pharmaceuticals Inc. vs
The Acta Group
The Acta Group United States

Global Chemical Product Innovation and Development

19 employees
Industrial
DJA Global Pharmaceuticals Inc. vs
dMed Biopharmaceutical Co., Ltd. dba Caidya
dMed Biopharmaceutical Co., Ltd. dba Caidya United States

dMed is now Caidya: Follow us at https://www.linkedin.com/company/caidya

Series D
171 employees
Biotechnology, Digital Health

FAQ About DJA Global Pharmaceuticals Inc.

The goal of DJA is to bridge the complex areas of discovery, pharmaceutical development and global regulatory science. DJA offers: 1. 100+ years collective experience in driving global regulatory approvals for drugs, biologics, combination products and devices. 2. Strategic and operational directio...
DJA Global Pharmaceuticals Inc. was founded in 2001.
DJA Global Pharmaceuticals Inc. is headquartered in United States.
DJA Global Pharmaceuticals Inc. operates in the following industries: Biotechnology, Pharmaceutical.
DJA Global Pharmaceuticals Inc. has approximately 11 employees.
Top alternatives and competitors to DJA Global Pharmaceuticals Inc. include Syner-G BioPharma Group, The Acta Group, dMed Biopharmaceutical Co., Ltd. dba Caidya, D2V Clinical, DUCK FLATS, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DJA Global Pharmaceuticals Inc. and Syner-G BioPharma Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DJA Global Pharmaceuticals Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy